2025 HCPCS code C1874

Supply of a drug-coated or biocompatible substance-covered stent with a delivery system for placement in a narrowed artery.

Hospitals should report C1874 with the appropriate revenue code and ensure the charge is not included in the procedure codes for stent placement. While previously included in the pass-through payment system, C1874 is now packaged into APC 656, but reporting is still required for OPPS claims to ensure correct procedure-to-device edits.

Medical necessity should be established based on the patient's clinical condition and the documented need for intervention to address the stenosis. Payer-specific guidelines for stent placement should be followed.

Placement of a coated stent in a stenotic artery by a provider.

IMPORTANT For a coated stent without delivery system, use C1875. For a non-coated stent with delivery system, use C1876.

In simple words: This code is for a special stent coated with medicine or a safe material, placed in a narrowed artery using a delivery system to help keep it open.

This code covers the supply of a stent coated with drugs or a biocompatible substance placed in a stenotic, or narrowed, artery. The stent includes a delivery system (balloon angioplasty catheter, introducer, and a sheath) that helps position it properly within the blood vessel. The coating helps prevent further thrombosis (blood clot formation) and maintains blood flow.

Example 1: A patient presents with a narrowed coronary artery. A drug-eluting stent with a delivery system is used to open the blockage and maintain blood flow. Code C1874 is reported for the stent supply., A patient with peripheral artery disease undergoes angioplasty. A heparin-coated stent with a delivery system is placed in the affected artery to keep it open. Code C1874 is used to report the coated stent., Following a coronary angiogram revealing a stenosis, a physician decides to place a stent coated with a biocompatible substance in the patient’s artery, utilizing the included delivery system. C1874 is reported.

Documentation should support the medical necessity of the stent placement, including diagnostic results (e.g., angiography) and procedural details. The type of coating (drug or biocompatible substance) should also be documented.

** Although the pass-through payment status has expired, reporting C1874 is mandatory for OPPS claims when used with procedures paid under OPPS.

** Only Enterprise users with EHR integration can access case-specific answers. Click here to request access.